124 related articles for article (PubMed ID: 6662162)
1. Cohort study of oestrogen treatment and the risk of endometrial cancer: evaluation of method and its applicability.
Persson I; Adami HO; Johansson E; Lindberg B; Manell P; Westerholm B
Eur J Clin Pharmacol; 1983; 25(5):625-32. PubMed ID: 6662162
[TBL] [Abstract][Full Text] [Related]
2. Risk of endometrial cancer after treatment with oestrogens alone or in conjunction with progestogens: results of a prospective study.
Persson I; Adami HO; Bergkvist L; Lindgren A; Pettersson B; Hoover R; Schairer C
BMJ; 1989 Jan; 298(6667):147-51. PubMed ID: 2538173
[TBL] [Abstract][Full Text] [Related]
3. The risk of endometrial neoplasia and treatment with estrogens and estrogen-progestogen combinations. First results of a cohort study after one to four completed years of observation.
Persson IR; Adami HO; Eklund G; Johansson ED; Lindberg BS; Lindgren A
Acta Obstet Gynecol Scand; 1986; 65(3):211-7. PubMed ID: 3739627
[TBL] [Abstract][Full Text] [Related]
4. Estrogen regimen of women with endometrial carcinoma. A retrospective case-control study at Radiumhemmet.
Obrink A; Bunne G; Collén J; Tjernberg B
Acta Obstet Gynecol Scand; 1981; 60(2):191-7. PubMed ID: 7246086
[TBL] [Abstract][Full Text] [Related]
5. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.
Key TJ; Pike MC
Br J Cancer; 1988 Feb; 57(2):205-12. PubMed ID: 3358913
[TBL] [Abstract][Full Text] [Related]
6. Endometrial cancer and patterns of use of oestrogen replacement therapy: a cohort study.
Paganini-Hill A; Ross RK; Henderson BE
Br J Cancer; 1989 Mar; 59(3):445-7. PubMed ID: 2930713
[TBL] [Abstract][Full Text] [Related]
7. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer.
Voigt LF; Weiss NS; Chu J; Daling JR; McKnight B; van Belle G
Lancet; 1991 Aug; 338(8762):274-7. PubMed ID: 1677110
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for breast and endometrial cancer in a cohort of women treated with menopausal oestrogens.
Bergkvist L; Persson I; Adami HO; Schairer C
Int J Epidemiol; 1988 Dec; 17(4):732-7. PubMed ID: 3225079
[TBL] [Abstract][Full Text] [Related]
9. The risk of endometrial carcinoma from oestrogen therapy of the menopause.
Klopper A
Acta Endocrinol Suppl (Copenh); 1980; 233():29-35. PubMed ID: 6773285
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of estrogen-treated women. A descriptive epidemiological study of a Swedish population. Part II.
Persson I; Adami HO; Lindberg BS; Johansson ED; Manell P
Acta Obstet Gynecol Scand; 1983; 62(4):297-302. PubMed ID: 6637403
[TBL] [Abstract][Full Text] [Related]
11. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.
Beresford SA; Weiss NS; Voigt LF; McKnight B
Lancet; 1997 Feb; 349(9050):458-61. PubMed ID: 9040575
[TBL] [Abstract][Full Text] [Related]
12. Practice and patterns of estrogen treatment in climacteric women in a Swedish population. A descriptive epidemiological study. Part I.
Persson I; Adami HO; Lindberg BS; Johansson ED; Manell P
Acta Obstet Gynecol Scand; 1983; 62(4):289-96. PubMed ID: 6637402
[TBL] [Abstract][Full Text] [Related]
13. Exogenous estrogens and development of breast and endometrial cancer.
Vakil DV; Morgan RW; Halliday M
Cancer Detect Prev; 1983; 6(4-5):415-24. PubMed ID: 6652636
[TBL] [Abstract][Full Text] [Related]
14. Oestrogens and obesity as risk factors for endometrial cancer in Italy.
La Vecchia C; Franceschi S; Gallus G; Decarli A; Colombo E; Mangioni C; Tognoni G
Int J Epidemiol; 1982 Jun; 11(2):120-6. PubMed ID: 7095961
[TBL] [Abstract][Full Text] [Related]
15. Review of epidemiologic studies of endometrial cancer and exogenous estrogen.
Cramer DW; Knapp RC
Obstet Gynecol; 1979 Oct; 54(4):521-6. PubMed ID: 492641
[TBL] [Abstract][Full Text] [Related]
16. The risk of acute myocardial infarction after oestrogen and oestrogen-progestogen replacement.
Falkeborn M; Persson I; Adami HO; Bergström R; Eaker E; Lithell H; Mohsen R; Naessén T
Br J Obstet Gynaecol; 1992 Oct; 99(10):821-8. PubMed ID: 1419993
[TBL] [Abstract][Full Text] [Related]
17. Oestrogen replacement and endometrial cancer. A statement by the British Gynaecological Cancer Group.
Lancet; 1981 Jun; 1(8234):1359-60. PubMed ID: 6113323
[TBL] [Abstract][Full Text] [Related]
18. Exogenous estrogen and endometrial carcinoma: case-control and incidence study.
McDonald TW; Annegers JF; O'Fallon WM; Dockerty MB; Malkasian GD; Kurland LT
Am J Obstet Gynecol; 1977 Mar; 127(6):572-80. PubMed ID: 190887
[TBL] [Abstract][Full Text] [Related]
19. Oestrogens and endometrial cancer: a point of view.
Lauritzen C
Clin Obstet Gynaecol; 1977 Apr; 4(1):145-67. PubMed ID: 192506
[TBL] [Abstract][Full Text] [Related]
20. Endometrial carcinoma risk factors, with special reference to the use of oestrogens.
Salmi T
Acta Endocrinol Suppl (Copenh); 1980; 233():37-43. PubMed ID: 6996404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
